Biote (BTMD) EBIT (2021 - 2026)

Biote's EBIT history runs 6 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, EBIT fell 67.33% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $1.4 million (up 361.26% YoY), while the FY2025 annual figure was $7.9 million, up 3605.63% from the prior year.
• EBIT was $3.2 million for Q1 2026 at Biote, up from -$20.8 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $68.4 million in Q4 2022 to a low of -$85.6 million in Q2 2022.
• Historically, EBIT has averaged $2.4 million across 5 years, with a median of $7.8 million in 2022.
• Biggest YoY gain for EBIT was 9150.29% in 2022; the steepest drop was 934.34% in 2022.
• A 5-year view of EBIT shows it stood at $68.4 million in 2022, then slumped by 91.95% to $5.5 million in 2023, then slumped by 619.81% to -$28.6 million in 2024, then climbed by 27.25% to -$20.8 million in 2025, then soared by 115.2% to $3.2 million in 2026.
• The last three EBIT figures came in at $3.2 million (Q1 2026), -$20.8 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.